Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × COVID-19 × 1 year × Clear all

Phase

Phase NA 8 Phase 2 4 Phase 3 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 30 Glioblastoma 30 Glioma 29 Pancreatic Neoplasms 24 Multiple Myeloma 22 Brain Neoplasms 20 Neoplasms 19 Recurrence 18 Squamous Cell Carcinoma of Head and Neck 15 Leukemia, Myeloid, Acute 15 Lung Neoplasms 14 Colorectal Neoplasms 14 Head and Neck Neoplasms 13 Triple Negative Breast Neoplasms 12 Sarcoma 12 Neoplasm Metastasis 11 Melanoma 11 Hematologic Neoplasms 11 Ovarian Neoplasms 10 Lymphoma 10 Colonic Neoplasms 9 Burkitt Lymphoma 9 Stomach Neoplasms 8 Polycystic Ovary Syndrome 8 Lymphoma, B-Cell 8 Endometrial Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Myasthenia Gravis 7

Interventions

NVX-CoV2373 adjuvated lipid nanoparticle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03305341 2025-06-11

COVSP-BCG

Medicine Invention Design, Inc

Phase EARLY_PHASE1 Active not recruiting

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡